Langbein S - Search Results

1

Renal cell carcinoma and oxidative stress: The lack of peroxisomes.

Frederiks WM, Bosch KS, Hoeben KA, van Marle J, Langbein S. Frederiks WM, et al. Among authors: langbein s. Acta Histochem. 2010 Jul;112(4):364-71. doi: 10.1016/j.acthis.2009.03.003. Epub 2009 Jun 4. Acta Histochem. 2010. PMID: 19500819

2

Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.

Langbein S, Frederiks WM, zur Hausen A, Popa J, Lehmann J, Weiss C, Alken P, Coy JF. Langbein S, et al. Int J Cancer. 2008 Jun 1;122(11):2422-8. doi: 10.1002/ijc.23403. Int J Cancer. 2008. PMID: 18302154 Free article.

3

Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.

Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P, Gabius HJ. Langbein S, et al. Histopathology. 2007 Nov;51(5):681-90. doi: 10.1111/j.1365-2559.2007.02852.x. Histopathology. 2007. PMID: 17927590

4

[Surgery of metastases in renal cell carcinoma].

Steinbach F, Langbein S, Allhoff EP. Steinbach F, et al. Among authors: langbein s. Urologe A. 2000 Jul;39(4):362-6; discussion 367. doi: 10.1007/s001200050371. Urologe A. 2000. PMID: 10957780 Review. German.

5

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.

Langbein S, Zerilli M, Zur Hausen A, Staiger W, Rensch-Boschert K, Lukan N, Popa J, Ternullo MP, Steidler A, Weiss C, Grobholz R, Willeke F, Alken P, Stassi G, Schubert P, Coy JF. Langbein S, et al. Br J Cancer. 2006 Feb 27;94(4):578-85. doi: 10.1038/sj.bjc.6602962. Br J Cancer. 2006. PMID: 16465194 Free PMC article.

6

Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique.

Langbein S, Lehmann J, Harder A, Steidler A, Michel MS, Alken P, Badawi JK. Langbein S, et al. Technol Cancer Res Treat. 2006 Feb;5(1):67-72. doi: 10.1177/153303460600500109. Technol Cancer Res Treat. 2006. PMID: 16417404 Free article.

7

Persistence, recurrence, and progression rates of superficial bladder tumours after resection using the differentiated technique.

Langbein S, Badawi K, Haecker A, Weiss C, Hatzinger M, Alken P, Siegsmund M. Langbein S, et al. Med Princ Pract. 2006;15(3):215-8. doi: 10.1159/000092184. Med Princ Pract. 2006. PMID: 16651838 Free article.

8

[Early instillation in superficial bladder carcinoma. Current status].

Langbein S, Häcker A, Badawi JK, Michel MS, Alken P. Langbein S, et al. Urologe A. 2004 Dec;43(12):1531-6. doi: 10.1007/s00120-004-0720-5. Urologe A. 2004. PMID: 15592710 Review. German.

9

Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides.

Schaaf A, Sagi S, Langbein S, Trojan L, Alken P, Michel MS. Schaaf A, et al. Among authors: langbein s. Urol Oncol. 2004 May-Jun;22(3):188-92. doi: 10.1016/j.urolonc.2004.01.010. Urol Oncol. 2004. PMID: 15271313

10

Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma.

Knoll T, Trojan L, Langbein S, Sagi S, Alken P, Michel MS. Knoll T, et al. Among authors: langbein s. Lasers Med Sci. 2004;19(1):33-6. doi: 10.1007/s10103-004-0299-5. Epub 2004 Jun 23. Lasers Med Sci. 2004. PMID: 15278722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page